Transcat, Inc.

NASDAQ:TRNS

Industrial - Distribution

Industrials
$100.12 +2.19%

+$2.00 today

Market cap
$941.61M
Beta
0.70
P/E (TTM)
150.2
EPS (TTM)
$0.62
52W Low $50.23High $94.76

Volume 0.11M

Average 0.16M

TRNS Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Transcat, Inc.NASDAQ: TRNS

Accounts Payables · Q4 FY2025 · quarter ended Mar 2026

Accounts payables declines year over year

Q4 FY2025 accounts payables of $444K fell 41.7% year over year, ahead of the -80.5% change in trailing-twelve-month accounts payables. Sequentially, it fell 78.8% from the prior quarter. Over 3 fiscal years it compounded at -15.5% a year.

Context

  • Accounts payables amounted to 0.3% of revenue in FY2025, down 1.5 pp from a year earlier.
  • Accounts payables increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -41.7% holds above the trailing-twelve-month pace of -80.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$444K-78.8% QoQ
Last fiscal yearMar 2026
$965K-80.5% YoY
LTMMar 2026
$965K-80.5% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-41.7%——
1 year-80.5%——
3-year CAGR-15.5%——
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
965K USD
Year-over-year change
-80.5%
4-year CAGR
-15.6%

Accounts Payables vs competitors

How TRNS compares with its peers on the latest reported figures

  • TRNS's LTM Mar 2026 accounts payables of $965K is the 8th largest of the 11 companies compared; the peer median is $504K.
  • Its year-over-year change of -80.5% is the 8th highest of 11, against a peer median of +62.1%.
  • Accounts payables amounts to 0.3% of revenue for TRNS, versus a peer median of 0.8%.
TRNS Competitors Peer median
Accounts Payables for TRNS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BIOBio-Rad Laboratories, Inc.LTM Jun 2026$34.6M +142.0%-89.8%1.3%
TECHBio-Techne CorporationLTM Sep 2026$24.54M +575.7%—2.0%
NEONeoGenomics, Inc.LTM Jun 2026$16.49M -289.5%—2.2%
QDELQuidelOrtho CorporationLTM Mar 2026$13.6M +197.1%+19.4%0.5%
UFPTUFP Technologies, Inc.LTM Jun 2026$9.9M +337.3%—1.6%
TICTIC Solutions, Inc.LTM Jun 2026$5.36M -650.5%-25.7%0.3%
MTDMettler-Toledo International Inc.LTM Jun 2026$5.02M -39.3%—0.1%
TRNSTranscat, Inc.LTM Mar 2026$965K -80.5%-15.5%0.3%
BLFSBioLife Solutions, Inc.LTM Mar 2026$948K -17.9%—1.0%
LABStandard BioTools Inc.LTM Mar 2026$571K -82.0%—0.7%
TKNOAlpha Teknova, Inc.LTM Mar 2026$60K +361.5%-6.3%0.1%
Peer median (excluding TRNS) $504K+62.1%-16.0%0.8%

Competitors are the stored peer set for TRNS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income11.38M10.69M13.65M14.52M5.38M
Depreciation & Amortization9.57M10.96M13.54M18.57M26.17M
Deferred Income Tax559K(186K)(1.6M)(5K)827K
Stock-Based Compensation2.33M3.38M4.51M3.25M7.55M
Change in Working Capital(6.34M)(8.05M)2.05M3.21M(11.9M)
Accounts Receivables(3.39M)74K406K(1.29M)(6.58M)
Inventory(122K)(3.38M)2.32M4.39M839K
Accounts Payables1.9M1.6M(5.01M)4.94M965K
Other Working Capital(4.73M)(6.34M)4.33M(4.83M)(7.13M)
Other Non-Cash Items122K162K459K(550K)6.83M
Operating Cash Flow17.62M16.95M32.62M38.99M34.85M
Capital Expenditures(10.15M)(9.41M)(13.28M)(13.2M)(15.3M)
Acquisitions (Net)(29.81M)(9.11M)(12.86M)(87.44M)(82.53M)
Purchases of Investments00(15.53M)00
Sales of Investments00000
Other Investing Activities109K10K016.63M0
Investing Cash Flow(39.85M)(18.51M)(41.67M)(84M)(97.82M)
Debt Repayment28.89M665K(44.96M)28.55M66.41M
Common Stock Issued1.49M658K77.27M1.87M842K
Common Stock Repurchased(6.68M)(447K)(4.91M)(3.57M)(469K)
Dividends Paid00000
Other Financing Activities0000(280K)
Financing Cash Flow23.69M876K27.4M26.86M66.5M
Effect of Forex Changes(625K)821K(228K)24K(103K)
Net Change in Cash836K135K18.12M(18.13M)3.43M
Free Cash Flow7.47M7.54M19.34M25.79M19.55M

Transcat, Inc.

NASDAQ:TRNS

Intrinsic Alpha fair value

Locked

Current Price

$100.12

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.